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Abstract 
 
L-Rhamnose was led, in a 14-step-sequence, to N2-(N,N-dimethylaminomethylene)-1’-O- 
(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]biopterin (23), an appropriately protected precursor for 
2’-O-glycosylation, while 4,6-di-O-acetyl-2,3-di-O-(4-methoxybenzyl)-α-D-glucopyranosy bromide (32), 
a novel glycosyl donor, was efficiently prepared from D-glucose in 8 steps.  The first synthesis of 
2’-O-(α-D-glucopyranosyl)biopterin (2a) was achieved by treatment of the key intermediate 23 with 32 in 
the presence of silver triflate and tetramethylurea, followed by successive removal of the protecting 
groups. 
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1. Introduction 
 
A variety of pterin derivatives having a hydroxyalkyl side-chain at C–6, a representative example 
being biopterin (1), have been found in nature.  Some of them isolated from certain prokaryotes 
possessed a glycosidic form having a sugar attached to the side-chain (Figure 1); for example, 
2’-O-(α-D-glucopyranosyl)biopterin (2a)1-4 and limipterin 
[2’-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)biopterin] (3)5 were isolated from cyanobacteria and a 
green sulfur photosynthetic bacterium, respectively.  Various other glycosides consisting of different 
pterins (such as ciliapterin,6 neopterin,7 and 6-hydroxymethylpterin8) and sugar moieties (such as 
D-ribose, D-mannose, D-galactose, and D-glucronic acid) have also been isolated from cyanobacteria, 
anaerobic photosynthetic bacteria, and chemoautotrophic archaebacteria, although the glycosidic linkages 
of some derivatives remain unclear.  Among these pterin glycosides, biopterin α-D-glucoside (2a) is the 
most noteworthy because of its abundant occurrence in various kinds of cyanobacteria, Anacystis 
nidulans,1 Oscillatoria sp.,2 Synechococcus sp.,3 and Spirulina platensis,4 but there has been no report for 
synthesis of 2a since its first discovery in 1958. 
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Figure 1.  Structures of biopterin and its glycosides 
 
The physiological function of the parent pterins has been studied in detail: for example, 1 plays, in 
the form of its tetrahydro derivative, an important role as an enzyme cofactor in aromatic amino acid 
hydroxylation9 and nitric oxide synthesis.10  By contrast, the functional roles of pterin glycosides have 
remained obscure, although some inhibitory activities against tyrosinase11 and photostabilization of 
photosynthetic pigments4,12 were reported for 2a.  Despite a considerable interest from the viewpoint of 
their biological activities and functions, as well as structural proof of hitherto reported natural products, 
attempts at preparation of pterin glycosides have so far scarcely been made, except for our synthetic 
studies on limipterin (3) and ciliapterin glycosides.13,14 
We reported in a previous paper13 that the glycosylation of a biopterin derivative whose two hydroxy 
groups were unprotected did not yield the 2’-O-(D-glucopyranosyl)biopterins with high selectivity: for 
example, treatment of N2-(N,N-dimethylaminomethylene)-3-[2-(4-nitrophenyl)ethyl]biopterin (4) with 
tetera-O-benzoyl-α-D-glucopyranosyl bromide (5)15 (3 mol equiv.) in the presence of tin (IV) chloride 
afforded 2’-O-(β-D-glucopyranosyl)biopterin (6) (41% yield), together with 1’-O-glycosyl isomer 7 
(15%) and 1’,2’-di-O-glycosyl derivative 8 (14%) (Scheme 1).  These results prompted us to develop a 
more efficient protocol for selective 2’-O-monoglycosylation.  In addition, we undertook preparation of 
an effective glycosyl donor leading to preponderant production of pterin α-glycosides instead of 
β-glycosides.  We give herein a full account of the first, efficient synthesis of the representative, natural 
pterin glycoside, 2’-O-(α-D-glucopyranosyl)biopterin (2a).16 
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Scheme 1. 
 
2. Results and discussion 
 
 A retrosynthetic analysis for 2a is outlined in Scheme 2.  The biopterin derivative 9, whose 
pyrimidine ring moiety and 1’-hydroxy group of the side chain are protected, can be perceived as the key 
precursor to accomplish complete 2’-O-glycosylation, while the pteridine ring formation of 9 would be 
achieved by condensation of 2,5,6-triamino-4-hydroxypyrimidine with the pentos-2-ulose 10, which 
would be derived from the 4-O-protected L-rhamnose 12 via the 3-O-protected 5-deoxy-L-arabinose 11.17  
A rational consideration of the available conditions to remove the protecting groups of the glycoside 
derived from 9 led us to employ p-methoxybenzyl (PMB) group for protection of 1’-hydroxy, 
N,N-dimethylaminomethylene group for 2-amino, and 2-(4-nitrophenyl)ethyl (NPE) group for N-3 of the 
ring.18 
 
 
Scheme 2. 
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L-Rhamnose, which served as the starting material to obtain the key intermediate 
5-deoxy-3-O-PMB-L-arabinose (19), was subjected to glycosidation with allyl alcohol in the presence of 
hydrochloric acid, followed by acetalization with 2,2-dimethoxypropane, providing allyl 
2,3-O-isopropylidene-α-L-rhamnopyranoside (13)19 (80%) along with the corresponding β-anomer (8%) 
(Scheme 3).  Treatment of 13 with p-methoxybenzyl chloride and sodium hydride in DMF gave the 
4-O-PMB derivative 14, which was then converted into the 1-propenyl glycoside 15 with potassium 
tert-butoxide in DMSO.  Hydrolysis of 15 in 70% acetic acid20 afforded 4-O-PMB-L-rhamnopyranose 
(16). 
The cleavage of C-1 of 16 was accomplished by application of the Hough and Taylor’s procedures21 
with a slight modification.  Namely, treatment of 16 with ethanethiol in the presence of 
p-toluenesulfonic acid in acetic acid gave the dithioacetal 17, which was then oxidized with 
m-chloroperbenzoic acid (mCPBA) to the corresponding sulfone 18.  Degradation of 18 with dilute 
aqueous ammonia afforded 5-deoxy-3-O-PMB-L-arbinofuranose (19).  The selective oxidation for 
2-hydroxy group of 19 with cupric acetate22 provided the L-erythro-pentos-3-ulose derivative 20. 
 
 
 
Scheme 3. 
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The pteridine ring formation of 20 with 2,5,6-triamino-4-hydroxypyrimidine sulfate was carried out 
in aqueous sodium bicarbonate solution to give an inseparable mixture of the biopterin derivative 21a and 
its C-7 substituted isomer 21b in a ratio of 78:22. These products were separated by column 
chromatography after having been subjected to the three-step-procedures for introduction of 
N,N-dimethylaminomethylene, acetyl, and NPE groups, thus providing 
2’-O-acetyl-N2-(N,N-dimethylaminomethylene)-1’-O-PMB-3-NPE-biopterin (22a) (53% overall yield 
from 20) and its C-7 substituted congener 22b (17%).14 
Methanolysis of 2’-O-acetyl-1’-O-PMB-biopterin derivative 22a in the presence of sodium 
methoxide provided the 1’-O-PMB derivative 23, a versatile precursor for 2’-O-monoglycosylation 
(Scheme 4).  Glycosylation of 23 was then examined by use of tetra-O-benzoyl-α-D-glucopyranosyl 
bromide (5) as a glycosyl donor in the presence of various activators.  While treatment of 23 with 5 in 
dichloromethane at room temperature in the presence of tetrabutylammonium bromide and 
N-ethyldiisopropylamine23 did not proceed, the same reaction in the presence of tin (IV) chloride13 as an 
activator resulted in the formation of diol 4, instead of glycosylation, by cleavage of PMB group.  
Efficient glycosylation of 23, however, was attained by the condensation with 3.0 mol equiv. of 5 in the 
presence of silver triflate (2.0 mol equiv.) and tetramethylurea (TMU)24 (1.0 mol equiv.) in 
dichloromethane at room temperature for 3 h, giving the 2’-O-(β-D-glucopyranosyl)biopterin derivative 
24 as a sole product in 75% yield. 
 
 
 
Scheme 4. 
 
Removal of the protecting groups of 24 was performed by the following 4-step-procedures: first, 
cleavage of PMB by use of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to afford 6 in 88%, then 
the three successive treatment with sodium methoxide (to cleave benzoyl groups), aqueous ammonia (to 
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cleave the N,N-dimethylaminomethylene group), and DBU (to cleave the NPE group)18 furnished 
2’-O-(β-D-glucopyranosyl)biopterin (2b), the anomeric isomer of the natural product, in 89% overall 
yield from 6.  Structure of 2b was unambiguously established as the corresponding hexaacetyl derivative 
25b obtained by usual acetylation.  Treatment of 25b with aqueous ammonia regenerated 2b 
quantitatively.  The precise 1H NMR parameters of 25b and 2b are summarized in Tables 1 and 2. 
This successful synthesis of biopterin 2’-O-β-D-glucoside (2b) led us to execute preparation of the 
natural product, biopterin 2’-O-α-D-glucoside (2a).  The stereoselective formation of the β-glycoside 24 
from 23 was mainly caused by participation of the 2-O-benzoyl group of the glycosyl donor 5 through the 
formation of an acyloxonium ion intermediate.25  Accordingly, in order to avoid such a neighboring 
group participation, we sought to introduce an ether substituent for protection of 2-OH of a glycosyl 
donor.  Taking into consideration the available combination of protecting groups employed for the 
synthetic pathway, PMB and acetyl groups were respectively chosen for protection of 2,3-OH and 
4,6-OH. We thus undertook the preparation of methyl 
4,6-di-O-acetyl-2,3-di-O-PMB-1-thio-β-D-glucopyranose (31) and its α-D-glucopyranosyl bromide 
derivative 32, the potential glycosyl donors for the pterin α-glycosides, starting with 
penta-O-acetyl-β-D-glucopyranose (26) 26 which is readily available from D-glucose (Scheme 5). 
 
 
Scheme 5. 
 
Treatment of 26 with thiourea and boron trifluoride etherate, followed by the action of methyl iodide 
and triethylamine, gave rise to the methyl 1-thio-β-D-glucopyranose derivative 27.27  Methanolysis of 
27 in the presence of sodium methoxide and the subsequent acetalization with 2,2-dimethoxypropane in 
the presence of p-toluenesulfonic acid provided the 4,6-O-isopropylidene derivative 28.  Treatment of 28 
with p-methoxybenzyl chloride and sodium hydride in DMF gave the 2,3-di-O-PMB derivative 29.  
Hydrolysis of 29 in 70% acetic acid provided methyl 2,3-di-O-PMB-1-thio-β-D-glucopyranoside (30), 
which was then acetylated to give the desired 4,6-di-O-acetyl derivative 31.  Then the thioglycoside 31 
was transformed to the correponding D-glucopyranosyl bromide 32 by the action of bromine in 
dichloromethane in the presence of 2,6-lutidine. 
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Glycosylation of the 1’-O-PMB-biopterin derivative 23 with glycosyl donors (31, 32) was examined 
under various conditions in the presence of activators (Scheme 6).  Treatment of 23 with the 
thioglycoside 31 in dichloromethane at room temperature in the presence of methyl triflate28 or 
N-iodosuccinimide-silver triflate29 as activators resulted in the formation of unidentified, decomposed 
compounds instead of the desired glycoside.30  Glycosylation of 23 with 4.0 mol equiv. of the glycosyl 
bromide 32 in dichloromethane in the presence of tetrabutylammonium bromide and 
N-ethyldiisopropylamine did not proceed, whereas the same reaction in the presence of silver triflate (2.0 
mol equiv.) and tetramethylurea (TMU) (1.0 mol equiv.) afforded an inseparable anomeric mixture 
(85:15) of the 2’-O-(α-D-glucopyranosyl)biopterin derivative 33a and its β-anomer 33b in 66% yield, 
along with the recovery of 23 (24%).  Separation of these isomers was achieved by removal of PMB 
groups and the subsequent acetylation.  Thus, the mixture of 33a,b was treated with DDQ in 
dichloromethane, followed by acetylation with acetic anhydride in pyridine, afforded the 
2’-O-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)biopterin derivative 34a in 51% (total yield from 23) 
and its β-anomer 34b in 9%.  The α-anomeric structure of 34a was derived from its J1,2 value (3.9 Hz) 
of 1H-NMR, while the larger J1,2 value (8.1 Hz) confirmed the β-form of 34b (Table 1). 
 
 
Scheme 6. 
 
Removal of the protecting groups of 34a was accomplished in the following manner:  34a was 
treated with aqueous ammonia to cleave the N,N-dimethylaminomethylene and acetyl groups and then 
with DBU to cleave NPE group, furnishing the desired 2’-O-(α-D-glucopyranosyl)biopterin (2a) in 90% 
overall yield.  For the purpose of structural confirmation and further purification, as in the case of the 
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β-isomer 2b, the α-isomer 2a was converted into the hexaacetyl derivative 25a, which regenerated 2a 
upon ammonolysis.  The precise parameters obtained on 1H and 13C NMR spectra for 2a and 25a are 
listed in Tables 1 and 2.  The spectral data of the synthetic α-glucoside 2a were found to be essentially 
identical with those reported for natural product4,11 (Table 2). 
The considerable difference between the J1’,2’ values of 2a (7.1 Hz) and 2b (4.9 Hz) indicates that 
these isomers are likely to exist in different rotamors along C-1’–C-2’ of the pterin side-chain.  
Accordingly we have calculated the most favorable conformations of 2a,b using semi-empirical 
(MOPAC PM3)31 methods.  As depicted in Figure 2, the optimized structure (A) for 2a has anti 
H–C-1’–C-2’–H conformation, whereas that for 2b (B) has the gauche conformation.  Moreover, an 
extraordinary upfield shift observed for the H-5 signal (δ 2.40) of the D-glucopyranosyl moiety of 2a in 
comparison with the relatively normal value (δ 3.43) of the corresponding β-glucoside (2b) could be 
explained in terms of such a conformation as H-5 of the sugar moiety locating above the pterin ring where 
an appreciable shielding effect is exerted, as visualized in its optimized structure (A). 
 
 
Figure 2.  The optimized structures A (for 2a) and B (for 2b) based on MOPAC PM3 methods. 
 
3. Conclusion 
 
We have developed a novel, effective way for selective preparation of both pterin 2’-O-β- and 
2’-O-α-glycosides.  By use of the key intermediate 1’-O-PMB-biopterin derivative 23 and the novel 
glycosyl donor 32 the first synthesis of biopterin α-D-glucoside (2a) was achieved.  This synthetic 
strategy has proved a useful method applicable to a series of other natural pterin glycosides and their 
analogs. 
 
4. Experimental 
 
4.1.  General procedures 
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All reactions were monitored by TLC (Merck Silica gel 60 F254) with an appropriate solvent system. 
Column chromatography was performed with Daiso Silica Gel IR-60/210w.  Components were detected 
by exposing the plates to UV light and/or 20% H2SO4-EtOH, with subsequent heating.  The NMR 
spectra were measured in CDCl3 with Varian Unity Inova AS600 (600 MHz for 1H, 151 MHz for 13C) or 
Mercury300 (300 MHz for 1H) at 23 °C.  Chemical shifts are reported as δ values relative to CHCl3 
(7.26 ppm) for 1H and CDCl3 (77.00 ppm) for 13C as an internal standard, unless otherwise stated.  
Optical rotations were measured with a JASCO P-1020 polarimeter in CHCl3. 
 
4.2.  Allyl 2,3-O-isopropylidene-α-L-rhamnopyranoside (13)19 and its β-anomer 
 
The following modification of the literature procedures was made.  To a solution of L-rhamnose 
monohydrate (3.56 g, 19.5 mmol) in allyl alcohol (28 mL) was added 4 M HCl in dioxane (6.0 mL, 24 
mmol).  The mixture was refluxed for 2 h, neutralized with TEA (10 mL), and concentrated in vacuo.  
The residue was dissolved in toluene (20 mL) and evaporated in vacuo to remove allyl alcohol three times.  
The residual syrup was dissolved in dry acetone (12 mL) and 2,2-dimethoxypropane (9.6 mL, 78 mmol) 
and then p-toluenesulfonic acid monohydrate (30 mg, 0.16 mmol) was added.  The mixture was stirred 
at rt for 10 h and then TEA (5 mL) was added.  The mixture was concentrated in vacuo and the residue 
was purified by column chromatography with 1:4 AcOEt-hexane to give 13 (3.83 g, 80%) (lit.19 68% 
yield on acetalization with acetone alone) and its β-anomer (372 mg, 7.8%). 
13: Colorless syrup; Rf = 0.67 (1:1 AcOEt-hexane); 1H-NMR (600 MHz, CDCl3) δ 1.29 (3H, d, J5,6 = 
6.3 Hz, H3-6), 1.35, 1.52 (3H each, 2s, CMe2), 2.45 (1H, br s, HO-4), 3.40 (1H, dd, J4,5 = 9.4, J3,4 = 7.2 
Hz, H-4), 3.68 (1H, dq, H-5), 4.00 (1H, ddt, J1’a,1’b = 12.7, J1’b,2’ = 6.4, J1’b,3’Z = J1’b,3’E = 1.3 Hz, Hb-1’of 
allyl), 4.09 (1H, dd, J2,3 = 5.7 Hz, H-3), 4.16 (1H, d, J1,2 = 0.7 Hz, H-2), 4.19 (1H, ddt, J1a’,2’ = 5.3, J1’a,3’E 
= J1’a,3’Z = 1.6 Hz, Ha-1’ of allyl), 5.00 (1H, br s, H-1), 5.21 (1H, dq, J2’,3’E = 10.5, J3’E,3’Z = 2.0 Hz, HE-3’ 
of allyl), 5.30 (1H, dq, J2’,3’Z = 17.1 Hz, HZ-3’ of allyl), 5.90 (1H, dddd, H-2’ of allyl). 
β-Anomer of 13: Pale yellow prisms; mp 52–53 °C (from AcOEt-hexane); [α]D27 +80.1° (c = 2.50, 
CHCl3); Rf = 0.38 (1:1 AcOEt-hexane); 1H-NMR (600 MHz, CDCl3) δ 1.34 (3H, d, J5,6 = 6.1 Hz, H3-6), 
1.39, 1.57 (3H each, 2s, CMe2), 2.25 (1H, br s, HO-4), 3.29 (1H, dq, J4,5 = 9.8 Hz, H-5), 3.53 (1H, dd, J3,4 
= 7.3 Hz, H-4), 4.02 (1H, dd, J2,3 = 5.6 Hz, H-3), 4.18 (1H, ddt, J1’a, 1’b = 12.9, J1’b,2’ = 6.8, J1’b,3’Z = J1’b,3’E 
= 1.2 Hz, Hb-1’ of allyl), 4.24 (1H, dd, J1,2 = 2.2 Hz, H-2), 4.43 (1H, ddt, J1’a,2’ = 4.9, J1’a,3’E = J1’a,3’Z = 1.6 
Hz, Ha-1’ of allyl), 4.78 (1H, d, H-1), 5.23 (1H, dddd, J2’,3’E = 10.5, J3’E,3’Z = 2.0 Hz, HE-3’ of allyl), 5.31 
(1H, dddd, J2’,3’Z = 17.3 Hz, HZ-3’ of allyl), 5.94 (1H, dddd, H-2’ of allyl).  Anal. Calcd for C12H20O5: 
C, 59.00; H, 8.25.  Found: C, 58.89; H, 8.45. 
 
4.3.  Allyl 2,3-O-isopropylidene-4-O-(4-methoxybenzyl)-α-L-rhamnopyranoside (14) 
 
To a solution of 13 (620 mg, 2.54 mmol) and p-methoxybenzyl chloride (0.69 mL, 5.09 mmol) in dry 
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DMF (6.0 mL) was added tetrabutylammonium iodide (281 mg, 0.726 mmol) and then sodium hydride 
(60% in oil, 305 mg, 7.26 mmol) at 0 °C.  The mixture was stirred at rt for 2 h and then saturated NH4Cl 
was added slowly at 0 °C.  The mixture was diluted with aqueous NaHCO3 and evaporated in vacuo.  
The residue was dissolved in CHCl3, washed with water, dried (MgSO4), and evaporated in vacuo.  The 
residue was purified by column chromatography with 1:9 AcOEt-hexane to give 14 (880 mg, 95%) as a 
colorless syrup: Rf = 0.24 (1:9 AcOEt-hexane); 1H NMR (300 MHz, CDCl3) δ 1.26 (3H, d, J5,6 = 6.3 Hz, 
H3-6), 1.38, 1.52 (3H each, 2s, CMe2), 3.20 (1H, dd, J4,5 = 9.9, J3,4 = 7.1 Hz, H-4), 3.69 (1H, dq, H-5), 
3.81 (3H, s, MeO), 3.98 (1H, ddt, J1’a,1’b = 13.1, J1b’,2’ = 6.3, J1’b,3’E = J1b’,3’Z = 1.3 Hz, Hb-1’ of allyl), 4.16 
(1H, ddt, J1’a,2’ = 5.3, J1’a,3’E = J1a’,3’Z = 1.5 Hz, Ha-1’ of allyl), 4.16 (1H, dd, J2,3 = 5.8, J1,2 = 0.7 Hz, H-2), 
4.27 (1H, dd, H-3), 4.56, 4.84 (1H each, 2d, 2J = 11.2 Hz, CH2O-4), 5.01 (1H, d, H-1), 5.20 (1H, dq, 
J2’,3’E = 10.4, J3’E,3’Z = 1.8 Hz, HE-3’ of allyl), 5.29 (1H, dq, J2’,3’Z = 17.2 Hz, HZ-3’ of allyl), 5.89 (1H, 
dddd, H-2’ of allyl), 6.89, 7.29 (2H each, 2d, Jo,m = 8.8 Hz, C6H4).  Anal. Calcd for C20H28O6: C, 65.91; 
H, 7.74.  Found: C, 66.11; H, 7.59. 
 
4.4.  (Z)-1-Propenyl 2,3-O-isopropylidene-4-O-(4-methoxybenzyl)-α-L-rhamnopyranoside (15) 
 
Compound 14 (880 mg, 2.41 mmol) was dissolved in dry DMSO (10 mL) and potassium 
tert-butoxide (770 mg, 6.85 mmol) was added in small portions.  The mixture was stirred at 100 °C for 
20 min and then saturated NH4Cl was added at 0 °C.  The mixture was diluted with aqueous NaHCO3 
and evaporated in vacuo.   The residue was dissolved in water and extracted with CHCl3 three times.  
The combined organic layers were dried (MgSO4) and evaporated in vacuo.  The residue was purified by 
column chromatography with 1:9 AcOEt-hexane to give 15 (837 mg, 95%) as a colorless syrup: Rf = 0.33 
(1:9 AcOEt-hexane); 1H NMR (300 MHz, CDCl3) δ 1.24 (3H, d, J5,6 = 6.3 Hz, H3-6), 1.39, 1.53 (3H each, 
2s, CMe2), 1.56 (3H, dd, J2’,3’ = 6.9, J1’,3’ = 1.8 Hz, H-3’ of propenyl), 3.21 (1H, dd, J4,5 = 9.9, J3,4 = 6.9 Hz, 
H-4), 3.68 (1H, dq, H-5), 3.80 (3H, s, MeO), 4.25 (1H, dd, J2,3 = 5.8, J1,2 = 0.7 Hz, H-2), 4.32 (1H, dd, 
H-3), 4.57 (1H, quint, J1’,2’ = 6.3 Hz, H-2’ of propenyl), 4.57, 4.84 (1H each, 2d, 2J = 11.2 Hz, CH2O-4), 
5.18 (1H, d, H-1), 6.14 (1H, dq, H-1’ of propenyl), 6.88, 7.29 (2H each, 2d, Jo,m = 8.7 Hz, C6H4).  Anal. 
Calcd for C20H28O6: C, 65.91; H, 7.74.  Found: C, 66.16; H, 7.63. 
 
4.5.  4-O-(4-Methoxybenzyl)-α ,β -L-rhamnoprranoses (16) 
 
Compound 15 (830 mg, 2.28 mol) was dissolved in 70% aqueous AcOH (10 mL) and the mixture 
was stirred at 35 °C for 24 h.  The mixture was concentrated in vacuo and the residue was purified by 
column chromatography with 1:1 AcOEt-hexane to give an inseparable anomeric mixture (α:β = ca. 1:1) 
of 16 (515 mg, 79%) as a colorless foam: Rf = 0.21 (AcOEt); 1H NMR [300 MHz, CDCl3 (D2O 
exchange)] δ 1.19*, 1.24 (3H each, 2d, J5,6 = 6.3*, 5.6 Hz, H3-6 of α*,β), 3.25 (2H, m, H-4,5 of β), 3.32 
(1H, t, J3,4 = J4,5 =9.1 Hz, H-4 of α), 3.56 (1H, dd, J3,4 = 8.7, J2,3 = 3.5 Hz, H-3 of β), 3.65*, 3.68 (3H, 2s, 
MeO of α*,β), 3.83-3.95 (4H, m, H-2,3,5 of α and H-2 of β), 4.465, 4.47, 4.68, 4.69 (1H each, 4d, 2J = 
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10.7 Hz, CH2O-4 of α,β), 4.62, 5.11* (1H, 2d, J1,2 = 1.0, 1.2* Hz, H-1 of α*,β), 6.77, 6.75, 7.18, 7.19 (2H 
each, 4d, Jo,m = 8.7 Hz, C6H4 of α,β).  Anal. Calcd for C14H20O6: C,59.14; H, 7.09.  Found: C, 59.02; H, 
7.26. 
 
4.6.  4-O-(4-Methoxybenzyl)-L-rhamnose diethyl dithioacetal (17) 
 
To a solution of 16 (95.4 mg, 0.336 mmol) in ethanethiol (3.6 mL) and AcOH (1.2 mL), 
p-toluenesulfonic acid monohydrate (6.4 mg, 0.034 mmol) was added at 0 °C.  The mixture was stirred 
at ca. 10 °C for 40 min, diluted with saturated NaHCO3, and concentrated in vacuo.  The residue was 
dissolved in CHCl3, washed with water, dried (MgSO4), and evaporated in vacuo.  The residue was 
purified by column chromatography with 1:2 AcOEt-hexane to give 17 (95.4 mg, 73%) as a colorless 
prisms: mp 47–48 °C (from AcOEt-hexane); [α]D26 –20.5° (c = 2.95, CHCl3); Rf = 0.41 (1:1 
AcOEt-hexane).  1H NMR (600 MHz, CDCl3) δ 1.27, 1.28 (3H each, 2t, 3J = 7.4 Hz, CH3CH2S), 1.29 
(3H, d, J5,6 = 6.6 Hz, H3-6), 2.48 (3H, br s, HO-2,3,5), 2.61, 2.72 (2H each, 2q, CH2S), 3.63 (1H, dd, J4,5 
= 4.4, J3,4 = 1.5 Hz, H-4), 3.80 (3H, s, MeO), 3.86 (1H, dd, J2,3 = 8.8, J1,2 = 2.4 Hz, H-2), 4.07 (1H, dd, 
H-3), 4.14 (1H, qd, H-5), 4.25 (1H, d, H-1), 4.59, 4.67 (1H each, 2d, 2J = 11.2 Hz, CH2O-4), 6.88, 7.28 
(2H each, 2d, Jo,m = 8.8 Hz, C6H4).  13C NMR (151 MHz, CDCl3) δ 14.60 (CH3CH2S), 14.71 
(CH3CH2S), 19.22 (C-6), 25.73 (CH2S), 26.16 (CH2S), 54.56 (C-1), 55.27 (MeO), 68.59 (C-5), 70.75 
(C-3), 72.90 (CH2O), 72.91 (C-2), 79.16 (C-4), 113.90 (C(m) of PMB), 129.87 (C(o) of PMB), 129.96 
(C(ipso) of PMB), 159.49 (C(p) of PMB).  Anal. Calcd for C18H30O5S2: C, 55.36; H, 7.42.  Found: C, 
55.48; H, 7.48. 
 
4.7.  1,6-Dideoxy-1,1-bis(ethylsulfonyl)-4-O-(4-methoxybenzyl)-L-mannitol (18) 
 
To a solution of 17 (199 mg, 0.510 mmol) in dry dioxane (4 mL) was added mCPBA (572 mg, 2.55 
mmol).  The mixture was stirred at rt for 1 h and then evaporated in vacuo.  The residue was diluted 
with CHCl3, washed with cold saturated NaHCO3, dried (MgSO4), and evaporated in vacuo.  The 
residue was purified by column chromatography with 1:1 AcOEt-hexane to give 18 (179 mg, 77%) as 
colorless needles: mp 115–116 °C (from AcOEt-hexane); [α]D27 –5.43° (c = 2.30, CHCl3); Rf = 0.20 (1:1 
AcOEt-hexane).  1H NMR (600 MHz CDCl3): δ = 1.31 (3H, d, J5,6 = 6.4 Hz, H3-6), 1.42, 1.44 (3H each, 
2t, 3J = 7.6 Hz, CH3CH2S), 2.37 (3H, br s, HO-2,3,5), 3.38, 3.57 (1H each, 2dq, 2J = 14.0 Hz, CH2S), 3.39, 
3.62 (1H each, 2dq, 2J = 14.0 Hz, CH’2S), 3.53 (1H, dd, J4,5 = 5.1, J3,4 = 1.7 Hz, H-4), 3.81 (3H, s, MeO), 
4.19 (1H, qd, H-5), 4.32 (1H, dd, J2,3 = 9.5 Hz, H-3), 4.53, 4.68 (1H each, 2d, 2J = 11.2 Hz, CH2O-4), 
4.66 (1H, dd, J1,2 = 1.0 Hz, H-2), 4.83 (1H, d, H-1), 6.90, 7.30 (2H each, 2d, Jo,m = 8.6 Hz, C6H4).  13C 
NMR (151 MHz, CDCl3): δ = 5.33 (CH3CH2S), 5.59 (CH3CH2S), 19.60 (C-6), 48.34 (CH3CH2S), 51.18 
(CH3CH2S), 55.30 (MeO), 68.19 (C-5), 69.92 (C-3), 70.22 (C-2), 72.80 (CH2O), 77.70 (C-1), 77.96 (C-4), 
114.10 (C(m) of PMB), 129.22 (C(o) of PMB), 130.29 (C(ipso) of PMB), 159.71 (C(p) of PMB).  Anal. 
Calcd for C18H30O9S2: C, 47.56; H, 6.65.  Found: C, 47.68; H, 6.72. 
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4.8.  5-Deoxy-3-O-(4-methoxybenzyl)-α ,β -L-arabinofuranoses (19)14  
 
Compound 18 (153 mg, 0.337 mmol) was dissolved in 10% aqueous ammonia (3 mL).  The mixture 
was stirred at rt for 10 h and then concentrated in vacuo.  The residue was purified by column 
chromatography with 1:2 AcOEt-hexane to give an inseparable mixture (40:60) of α- and β-anomers of 
19 (70.1 mg, 82%) as a colorless syrup: Rf = 0.15 (1:1 AcOEt-hexane), 0.54 (AcOEt).  1H NMR spectra 
were in accord with previously published data.14 
 
4.9.  5-Deoxy-3-O-(4-methoxybenzyl)-α ,β -L-erythro-pentos-2-uloses (20)14  
 
Compound 19 (282 mg, 1.11 mmol) was dissolved in MeOH (6 mL) and water (3 mL).  The 
solution was refluxed and then cupric acetate hydrate (1.44 g, 7.23 mmol) was added.  The mixture was 
refluxed for 1 h and then precipitates were filtered off and washed with ethyl acetate.  The filtrate was 
evaporated in vacuo and the residue was separated by column chromatography with 1:3 AcOEt-hexane to 
give 20 (142 mg, 51% yield, lit,14 46%) as a colorless syrup: Rf = 0.25–0.33 (1:1 AcOEt-hexane).  From 
the slower-eluting fraction, compound 17 (55.2 mg, 20%) was recovered. 
 
4.10. N2-(N,N-Dimethylaminomethylene)-1’-O-(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]-
biopterin (23)14  
 
By use of the same procedures described in the literature,14 compound 20 was converted into 23 in 
five steps: Rf = 0.60 (1:9 MeOH-CHCl3). 
 
4.11.  N2-(N,N-Dimethylaminomethylene)-1’-O-(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]-2’- 
O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)biopterin (24) 
 
To a solution of 23 (56.0 mg, 0.100 mmol), glycosyl bromide 5 (200 mg, 0.303 mmol) and TMU 
(0.012 mL, 0.10 mmol) in dry CH2Cl2 (1.0 mL) was added silver triflate (56.0 mg, 0.218 mmol).  The 
mixture was stirred at rt for 3 h in the dark, diluted with CHCl3, and filtered through Celite.  The filtrate 
was washed with aqueous NaHCO3, dried (Na2SO4), and evaporated in vacuo.  The residue was purified 
by column chromatography with 2:1 AcOEt-hexane to give 24 (85.6 mg, 75%) as a pale yellow foam: Rf 
= 0.38 (AcOEt); 1H NMR (600 MHz, CDCl3), see Table 1.  Anal. Calcd for C62H57N7O15: C, 65.31; H, 
5.04.  Found: C, 65.18; H, 4.96. 
 
4.12.  N2-(N,N-Dimethylaminomethylene)-3-[2-(4-nitrophenyl)ethyl]-2’-O-(2,3,4,6-terta-O- 
benzoyl-β-D-glucopyranosyl)biopterin (6)13  
 
 13 
To a solution of 22 (54.4 mg, 0.0477 mmol) in CH2Cl2 (1.0 mL) containing water (0.10 mL) was 
added DDQ (16.2 mg, 0.0716 mmol).  The mixture was stirred at rt for 2 h and then evaporated in vacuo.  
The residue was purified by column chromatography with 1:99 MeOH-CHCl3 to give 6 (40.6 mg, 83%) 
as a pale yellow syrup: Rf = 0.63 (1:9 MeOH-CHCl3); [α]D20 +37.1° (c 2.17, CHCl3).  1H NMR spectra 
were in accord with previously published data.13  Anal. Calcd for C54H49N7O14: C, 63.59; H, 4.84.  
Found: C, 63.44; H, 4.99. 
 
4.13.  2’-O-(β-D-Glucopyranosyl)biopterin (2b) 
 
4.13.1. From 6.  Compound 6 (54.1 mg, 0.0530 mmol) was dissolved in MeOH (2.0 mL) and a 28% 
methanolic NaOMe (0.03 mL, 0.15 mmol) was added at 0 °C.  The mixture was stirred at rt for 1 h and 
neutralized with Amberlite IR-120(H+).  The resin was filtered off and the filtrate was evaporated in 
vacuo.  The residue was dissolved in MeOH (3.0 mL) and 28% aqueous ammonia solution (3.0 mL) was 
added.  The mixture was stirred at rt for 12 h and evaporated in vacuo.  The residue was dissolved in 
DMF (1.0 mL) and DBU (0.050 mL, 0.32 mmol) was added.  The mixture was stirred at rt for 12 h, 
diluted with water (3.0 mL), and neutralized with Amberlite FPC3500(H+).  The resin was filtered off 
and the filtrate was evaporated in vacuo.  The residue was washed with CHCl3 and dried under reduced 
pressure to give 2b (18.7 mg, 89% from 6) as a yellow powder. 
 
4.13.2. From 25b.  Compound 25b (26.0 mg, 0.0399 mmol) was dissolved in MeOH (2.0 mL) and 28% 
aqueous ammonia solution (1.0 mL) was added.  The mixture was stirred at rt for 12 h and evaporated in 
vacuo.  The residue was washed with CHCl3 to give 2b (15.6 mg, 98%): Rf = 0.23 (5:3:1 
i-PrOH-AcOEt-H2O); 1H NMR (600 MHz, D2O) and 13C NMR (151 MHz, D2O and DMSO-d6), see 
Table 2.  Anal. Calcd for C15H21N5O8: C, 45.11; H, 5.30.  Found: C, 44.89; H, 5.53. 
 
4.14.  Di-N2:1’-O-acetyl-2’-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)biopterin (25b) 
 
Compound 1b (18.7 mg, 0.0468 mmol) was dissolved in pyridine (2.0 mL) and then acetic anhydride 
(1.0 mL) was added at 0 °C.  The mixture was stirred at rt for 12 h and evaporated in vacuo.  The 
residue was purified by column chromatography with AcOEt to give 25b (28.0 mg, 92%) as a pale yellow 
syrup: Rf = 0.52 (1:9 MeOH:CHCl3); 1H NMR (600 MHz, CDCl3), see Table 1.  Anal. Calcd for 
C27H33N5O14: C, 49.77; H, 5.10.  Found: C, 49.92; H, 5.02. 
 
4.15.  Methyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside (27)27 
 
The following modification of the literature procedures was made.27  To a solution of 26 (5.41 g, 
13.9 mmol) in dry acetonitrile (28 mL), were added thiourea (1.17 g, 15.4 mmol) and BF3-etherate (3.7 
mL, 29.1 mmol).  The mixture was refluxed for 20 min and then TEA (23.2 mL, 166 mmol) and methyl 
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iodide (8.6 mL, 139 mmol) were slowly added at 0 °C.  The reaction mixture was stirred at rt for 2 h and 
concentrated in vacuo.  The residue was dissolved in CHCl3 and then the mixture was washed with brine, 
dried (Na2SO4), and evaporated in vacuo.  The residue was purified by column chromatography with 1:5 
AcOEt-hexane to give 27 [4.66 g, 89% (lit.27 57% yield)] as colorless crystals: mp 89-90 °C (from 
AcOEt-hexane); Rf = 0.26 (1:2 AcOEt-hexane); 1H NMR (600 MHz, CDCl3) δ 2.01, 2.03, 2.07, 2.09 (3H 
each, 4s, AcO-2,3,4,6), 2.17 (3H, s, SMe), 3.73 (1H, ddd, J4,5 = 10.0, J5,6a = 4.9, J5,6b = 2.4 Hz, H-5), 4.15 
(1H, dd, J6a,6b = 12.5 Hz, Hb-6), 4.25 (1H, dd, Ha-6), 4.39 (1H, d, J1,2 = 10.0 Hz, H-1), 5.07 (1H, dd, J3,4 = 
9.5 Hz, H-4), 5.08 (1H, dd, J2,3 = 9.5 Hz, H-2), 5.23 (1H, t, H-3). 
 
4.16.  Methyl 4,6-O-isopropylidene-1-thio-β-D-glucopyranoside (28) 
 
Compound 27 (607 mg, 1.60 mmol) was dissolved in dry MeOH (3.5 mL) and then a 28% methanoic 
sodium methoxide (0.87 mL, 4.33 mmol) was added at 0 °C.  The mixture was stirred at rt for 2 h and 
neutralized with Amberlite IR-120(H+).  The resin was filtered off and the filtrate was evaporated in 
vacuo.  The residue was dissolved in dry DMF (5.0 mL) and then 2,2-dimethoxypropane (0.79 mL, 6.42 
mmol) and p-toluenesulfonic acid monohydrate (24 mg, 0.13 mmol) were added.  The mixture was 
stirred at rt for 12 h and then pyridine (0.5 mL) was added.  The mixture was concentrated in vacuo and 
the residue was purified by column chromatography with 1:2 AcOEt-hexane to give 28 (364 mg, 90%) as 
a colorless syrup: Rf = 0.16 (1:1 AcOEt-hexane); 1H NMR (600 MHz, CDCl3) δ 1.43, 1.50 (3H each, 2s, 
Me2C), 2.21 (3H, s, SMe), 3.00, 3.25 (1H each, 2br s, HO-2,3), 3.32 (1H, ddd, J5,6b = 10.3, J4,5 = 9.6, J5,6a 
= 5.4 Hz, H-5), 3.47 (1H, dd, J1,2 = 9.8, J2,3 = 8.3 Hz, H-2), 3.57 (1H, t, J3,4 = 9.3 Hz, H-4), 3.67 (1H, dd, 
H-3), 3.75 (1H, t, J6a,6b = 10.9 Hz, Hb-6), 3.93 (1H, dd, Ha-6), 4.32 (1H, d, H-1).  Anal. Calcd for 
C10H18O5S: C, 47.98; H, 7.25.  Found: C, 48.11; H, 7.02. 
 
4.17.  Methyl 4,6-O-isopropylidene-2,3-di-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranoside (29) 
 
Compound 28 (778 mg, 3.11 mmol), p-methoxybenzyl chloride (2.10 mL, 15.5 mmol) and 
tetrabutylammonium iodide (344 mg, 0.93 mmol) were dissolved in dry DMF (30 mL) and then sodium 
hydride (60% in oil, 621 mg, 15.5 mmol) was added with stirring at 0 °C.  The mixture was stirred at rt 
for 10 h, diluted with saturated NH4Cl, and evaporated in vacuo.  The residue was dissolved in CHCl3, 
washed with water, dried (Na2SO4), and evaporated in vacuo.  The residue was purified by column 
chromatography with 1:6 AcOEt-hexane to give 29 (1.25 g, 82% yield) as colorless prisms: mp 80–81 °C 
(from AcOEt-hexane); [α]D26 +4.25° (c = 1.44, CHCl3); Rf = 0.34 (1:4 AcOEt-hexane); 1H NMR (600 
MHz, CDCl3) δ 1.43, 1.51 (3H each, 2s, Me2C), 2.20 (3H, s, SMe), 3.26 (1H, dt, J5,6b = 10.2, J4,5 = 9.7, 
J5,6a = 5.4 Hz, H-5), 3.38 (1H, dd, J1,2 = 9.8, J2,3 = 8.5 Hz, H-2), 3.60 (1H, t, J3,4 = 9.1 Hz, H-3), 3.69 (1H, 
t, H-4), 3.75 (1H, t, J6a,6b = 11.0 Hz, Hb-6), 3.80 (6H, s, MeO), 3.93 (1H, dd, Ha-6), 4.37 (1H, d, H-1), 
4.69, 4.72*, 4.74*, 4.80 (1H each, 4d, 2J = 11.0, 10.0* Hz, CH2O-2,3), 6.855, 6.86 (1H each, 2d, Jo,m = 8.6 
Hz, m of PMB), 7.28, 7.30 (2H each, 2d, o of PMB).  Anal. Calcd for C26H34O7S: C, 63.65; H, 6.99.  
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Found: C, 63.81; H, 7.01. 
 
4.18.  Methyl 2,3-di-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranoside (30) 
 
To a solution of 29 (240 mg, 0.489 mmol) in MeOH (1.5 mL) was added 70% aqueous AcOH (3.0 
mL).  The mixture was stirred at rt for 10 h and evaporated in vacuo.  The residue was purified by 
column chromatography with 1:1 AcOEt-hexane to give 30 (213 mg, 97% yield) as colorless needles: mp 
45-46 °C (from AcOEt-hexane); [α]D26 -16.2° (c = 1.81, CHCl3); Rf = 0.14 (1:1 AcOEt-hexane); 1H NMR 
(600 MHz, CDCl3) δ 1.97 (2H, br s, HO-4,6), 2.24 (3H, s, SMe), 3.33 (1H, ddd, J4,5 = 9.4, J5,6b = 5.2, J5,6a 
= 3.4 Hz, H-5), 3.38 (1H, t, J1,2 = 9.5, J2,3 = 8.8 Hz, H-2), 3.45 (1H, t, J3,4 = 8.9 Hz, H-3), 3.53 (1H, t, 
H-4), 3.74 (1H, dd, J6a,6b = 11.9 Hz, Hb-6), 3.80 (6H, s, MeO), 3.87 (1H, dd, Ha-6), 4.39 (1H, d, H-1), 
4.64, 4.70*, 4.86*, 4.91 (1H each, 4d, 2J = 11.3, 9.8* Hz, CH2O-2,3), 6.88, 6.89 (2H each, 2d, Jo,m = 8.5 
Hz, m of PMB), 7.26, 7.36 (2H each, 2d, o of PMB).  Anal. Calcd for C23H30O7S: C, 61.31; H, 6.71.  
Found: C, 61.10; H, 6.93. 
 
4.19.  Methyl 4,6-di-O-acetyl-2,3-di-O-(4-methoxybenzyl)-1-thio-β-D-glucopyranoside (31) 
 
Compound 30 (295 mg, 0.655 mmol) was dissolved in pyridine (3.0 mL) and then acetic anhydride 
(0.62 mL, 6.56 mmol) was added at 0 °C.  The mixture was stirred at rt for 12 h and evaporated in vacuo.  
The residue was purified by column chromatography with 1:3 AcOEt-hexane to give 31 (342 mg, 98% 
yield) as colorless needles: mp 82–83 °C (from AcOEt-hexane); [α]D26 -0.69° (c = 1.21, CHCl3); Rf = 
0.22 (1:2 AcOEt-hexane); 1H NMR (600 MHz, CDCl3) δ 1.94, 2.06 (3H each, 2s, AcO-4,6), 2.22 (1H, s, 
SMe), 3.48 (1H, t, J1,2 = 9.8, J2,3 = 8.8 Hz, H-2), 3.54 (1H, ddd, J4,5 = 9.8, J5,6a = 5.2, J5,6b = 2.4 Hz, H-5), 
3.61 (1H, t, J3,4 = 9.5 Hz, H-3), 3.80 (6H, s, MeO), 4.08 (1H, dd, J6a,6b = 12.2 Hz, Hb-6), 4.20 (1H, dd, 
Ha-6), 4.35 (1H, d, H-1), 4.59, 4.67*, 4.77, 4.81* (1H each, 4d, 2J = 11.0, 10.1* Hz, CH2O-2,3), 5.02 (1H, t, 
H-4), 6.855, 6.86 (2H each, 2d, Jo,m = 8.8 Hz, m of PMB), 7.18, 7.30 (2H each, 2d, o of PMB).  Anal. 
Calcd for C27H34O9S: C, 60.66; H, 6.41.  Found: C, 60.58; H, 6.55. 
 
4.20.  4,6-Di-O-acetyl-2,3-di-O-(4-methoxybenzyl)-α-D-glucopyranosyl bromide (32) 
 
Compound 31 (650 mg, 1.22 mmol) and 2,6-lutidine (0.40 mL, 3.41 mmol) were dissolved in dry 
CH2Cl2 (4.0 mL) and then bromine (0.15 mL, 2.92 mmol) was added with stirring at 0 °C.  The mixture 
was stirred at rt for 2 h and then cyclohexene (0.30 mL, 2.96 mmol) was added.  The mixture was 
concentrated in vacuo and the residue was dissolved in AcOEt.  The insoluble matter was filtered off 
and the filtrate was evaporated in vacuo.  The residue was purified by column chromatography with 1:4 
AcOEt-hexane to give 32 (623 mg, 90%) as a colorless syrup: Rf = 0.42 (1:2 AcOEt-hexane); 1H NMR 
(600 MHz, CDCl3) δ 1.95, 2.05 (3H each, 2s, AcO-4,6), 3.53 (1H, dd, J2,3 = 9.2, J1,2 = 3.9 Hz, H-2), 3.80, 
3.81 (3H each, 2s, MeO), 3.92 (1H, t, J3,4 = 9.5 Hz, H-3), 4.02 (1H, dd, J6a,6b = 12.5, J5,6b = 2.1 Hz, Hb-6), 
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4.14 (1H, ddd, J4,5 = 10.4, J5,6a = 4.6 Hz, H-5), 4.26 (1H, dd, Ha-6), 4.58*, 4.62, 4.67, 4.80* (1H each, 4d, 
2J = 11.6, 11.3* Hz, CH2O-2,3), 5.05 (1H, dd, H-4), 6.26 (1H, d, H-1), 6.86, 6.88 (2H each, 2d, Jo,m = 8.6 
Hz, m of PMB), 7.19, 7.29 (2H each, 2d, o of PMB).  Anal. Calcd for C26H31BrO9: C, 55.03; H, 5.51.  
Found: C, 54.91; H, 5.74. 
 
4.21. N2-(N,N-Dimethylaminomethylene)-1’-O-(4-methoxybenzyl)-3-[2-(4-nitrophenyl)ethyl]-2’-O- 
[4,6-di-O-acetyl-2,3-di-O-(4-metoxybenzyl)-α-D-glucopyranosyl]biopterin (33a) and its β-anomer 
33b 
 
To a solution of the biopterin derivative (23) (30.0 mg, 0.0534 mmol), the D-glucopyranosyl bromide 
(32) (122 mg, 0.21 mmol) and TMU (0.0064 mL, 0.054 mmol) in dry CH2Cl2 (2.0 mL), was added silver 
triflate (28.0 mg, 0.109 mmol).  The mixture was stirred at rt for 3 h and the suspension was filtered 
through Celite.  The residue was washed with CHCl3 and the filtrate was treated with saturated NaHCO3.  
The mixture was extracted with CHCl3 three times.  The combined organic layers were dried (Na2SO4) 
and evaporated in vacuo.  The residue was purified by column chromatography with 1:1 AcOEt-hexane 
to give an inseparable anomeric mixture (85:15) of 33a and 33b (37.0 mg, 66%) as a pale yellow syrup: 
Rf = 0.50 (AcOEt).  From the slower-eluting fraction, compound 23 (7.2 mg, 24% recovery) was 
recovered: Rf = 0.12 (AcOEt). 
33a: 1H NMR (600 MHz, CDCl3), see Table 1. 
 
4.22. 1’-O-Acetyl-N2-(N,N-dimethylaminomethylene)-3-[2-(4-nitrophenyl)ethyl]-2’-O-(2,3,4,6- 
tetra-O-acetyl-α-D-glucopyranosyl)biopterin (34a) and its β-anomer 34b 
 
To a solution of 33a,b (59.0 mg, 0.0563 mmol) in CH2Cl2 (2.0 mL) containing water (0.2 mL) was 
added DDQ (154 mg, 0.68 mmol).  The mixture was stirred at rt for 2 h and then diluted with CHCl3.  
The mixture was washed with aqueous NaHCO3, dried (Na2SO4), and evaporated in vacuo.  The residue 
was dissolved in dry pyridine (2.0 mL) and then acetic anhydride (0.27 mL, 2.82 mmol) was added at 
0 °C.  The mixture was stirred at rt for 12 h and then evaporated in vacuo.  The residue was purified by 
column chromatography with 2:1 AcOEt-hexane to give 34a (35.2 mg, 51% from 23) and 34b (6.2 mg, 
9%). 
34a: Pale yellow syrup; Rf = 0.27 (AcOEt); 1H NMR (600 MHz, CDCl3), see Table 1.  Anal. Calcd 
for C36H43N7O15: C, 53.13; H, 5.33.  Found: C, 53.01; H, 5.49. 
34b: Pale yellow syrup; Rf = 0.30 (AcOEt); 1H NMR (600 MHz, CDCl3), see Table 1. 
 
4.23.  2’-O-(α-D-Glucopyranosyl)biopterin (2a) 
 
4.23.1. From 34a.  Compound 34a (30.2 mg, 0.0371 mmol) was dissolved in MeOH (2.0 mL) and 28% 
aqueous ammonia solution (2.0 mL) was added.  The mixture was stirred at room temperature for 12 h 
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and then evaporated in vacuo.  The residue was dissolved in DMF (2.0 mL) and DBU (0.027 mL, 0.18 
mmol) was added.  The mixture was stirred at rt for 12 h and neutralized with Amberlite FPC3500(H+).  
The resin was filtered off and the filtrate was evaporated in vacuo.  The residue was washed with CHCl3 
and dried under reduced pressure to give 2a (13.4 mg, 90%). 
 
4.23.2. From 25a.  Compound 25a (18.0 mg, 0.0276 mmol) was dissolved in MeOH (1.0 mL) and 28% 
aqueous ammonia solution (1.0 mL) was added.  The mixture was stirred at rt for 12 h and then 
evaporated in vacuo.  The residue was washed with CHCl3 and dried under reduced pressure to give 2a 
(10.4 mg, 94%) as a pale yellow solid: Rf = 0.11 (5:3:1 2-PrOH-AcOEt-H2O); 1H NMR (600 MHz, D2O) 
and 13C NMR (151 MHz, D2O and DMSO-d6), see Table 2.  Anal. Calcd for C15H21N5O8: C, 45.11; H, 
5.30.  Found: C, 45.01; H, 5.50. 
 
4.24.  Di-N2:1’-O-Acetyl-2’-O-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)biopterin (25a) 
 
Compound 2a (13.4 mg, 0.0336 mmol) was dissolved in dry DMF (1.0 mL) and dry pyridine (1.0 
mL) and then acetic anhydride (0.17 mL, 1.84 mmol) was added at 0 °C.  The mixture was stirred at rt 
for 12 h and then evaporated in vacuo.  The residue was purified by column chromatography with 4:1 
AcOEt-hexane to give 25a (19.6 mg, 90%) as a yellow syrup: Rf = 0.29 (AcOEt); 1H NMR (600 MHz, 
CDCl3), see Table 1.  Anal. Calcd for C27H33N5O14: C, 49.77; H, 5.10.  Found: C, 49.99; H, 5.29. 
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